Diabetic Macular Edema (DME) Clinical Trials

Find Diabetic Macular Edema (DME) Clinical Trials Near You

Lactiplantibacillus Plantarum 299v Probiotic Probiotic Supplementation in Patients With Diabetic Macular Edema

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY

This pilot prospective, interventional, longitudinal study, aims to evaluate the potential benefits of the probiotic supplement Lactobacillus plantarum 299v in patients with diabetic macular edema (DME). The study seeks to address the following questions: 1. Does central macular thickness on optical coherence tomography decrease after 4 months of supplementation? 2. Is visual acuity improved at 1, 2, 3, and 4 months following initiation of supplementation? 3. Is the number of anti-VEGF injections reduced following initiation of supplementation? Outcomes will be compared to a control group, using historic retrospective data. Participants will take Lactobacillus plantarum 299v orally twice daily for four months.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Age of at least 18 years, presence of DME at the current clinical visit

Locations
United States
Massachusetts
Mass Eye and Ear
RECRUITING
Boston
Contact Information
Primary
Demetrios G. Vavvas, MD PhD
Demetrios_Vavvas@meei.harvard.edu
6175736874
Time Frame
Start Date: 2026-06-23
Estimated Completion Date: 2027-09-01
Participants
Target number of participants: 36
Treatments
Experimental: Main Arm - twice daily for 4 months
This is the only arm in this study. All participants will receive 4 months of Lactobacillus plantarum supplementation.
Sponsors
Leads: Massachusetts Eye and Ear Infirmary

This content was sourced from clinicaltrials.gov

Similar Clinical Trials